Background illustration for clinical trials search

Paid Clinical Trials Tuscaloosa

Discover 870 paid clinical trials in Tuscaloosa, Alabama. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

TEMPUS ARIES: A Biobank Registry Platform Study in Oncology

for
Cancer
Location: Birmingham AL, Atlanta GA, Carterville IL, O'Fallon IL,
Sponsor: Tempus AI

Sex: All

Age: 18 - 70+

Code: NCT06207032

Recruiting

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

for
NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer,
Location: Birmingham AL, Atlanta GA, Nashville TN, Athens GA,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT06881784

Phase 3, Recruiting

Pan-tumor MRD Study

for
Muscle Invasive Bladder Urothelial Carcinoma, Esophageal Cancer,
Location: Birmingham AL, Atlanta GA, Covington LA, Little Rock AR,
Sponsor: Paradigm Health

Sex: All

Age: 18+

Code: NCT06605404

Recruiting

GEMINI-NSCLC: NSCLC Biomarker Study

for
Non-Small Cell Lung Cancer
Location: Birmingham AL, Atlanta GA, Memphis TN, Carterville IL,
Sponsor: Tempus AI

Sex: All

Age: 18+

Code: NCT05236114

Recruiting

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Birmingham AL, Atlanta GA, Nashville TN, Greenville SC,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07518186

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

for
Triple Negative Breast Cancer
Location: Birmingham AL, Huntsville AL, Newnan GA, Marietta GA,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT05633654

Phase 3, Recruiting

Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)

for
Pulmonary Embolism
Location: Birmingham AL, Knoxville TN, Bradenton FL,
Sponsor: Innova Vascular, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06041594

Recruiting

Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation

for
Atrial Fibrillation (AF), Persistant Atrial Fibrillation,
Location: Birmingham AL, Atlanta GA, Jonesboro AR, Lexington KY,
Sponsor: Arga Medtech SA

Sex: All

Age: 18 - 70+

Code: NCT06784466

Recruiting

A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation

for
Atrial Fibrillation
Location: Birmingham AL, Jonesboro AR, Edgewood KY,
Sponsor: Biosense Webster, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07527299

Recruiting

The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.

for
Paroxysmal Atrial Fibrillation
Location: Birmingham AL, Mobile AL, Atlanta GA, Louisville KY,
Sponsor: Heart Rhythm Clinical and Research Solutions, LLC

Sex: All

Age: 18+

Code: NCT06324201

Recruiting

A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence

for
Narcolepsy Type 1, Narcolepsy Type 2
Location: Birmingham AL, Flowood MS, Atlanta GA, Rincon GA,
Sponsor: Centessa Pharmaceuticals (UK) Limited

Sex: All

Age: 18 - 70

Code: NCT07598708

Phase 2, Phase 3, Recruiting

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

for
Ulcerative Colitis, Crohn's Disease
Location: Birmingham AL, Mobile AL, Atlanta GA, Southaven MS,
Sponsor: Takeda

Sex: All

Age: 18 - 70+

Code: NCT06581328

Phase 4, Recruiting

A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions

for
Narcolepsy Type 1
Location: Birmingham AL, Atlanta GA, Gainesville GA, Columbia SC,
Sponsor: Takeda

Sex: All

Age: 16 - 70

Code: NCT05816382

Phase 2, Phase 3, Recruiting

A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH

for
Narcolepsy, Idiopathic Hypersomnia
Location: Birmingham AL, Nashville TN, Rincon GA, Denver NC,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07625280

Phase 3, Recruiting

Prevention of Breakthrough CINV in Patients Receiving Moderately or Highly Emetogenic Chemotherapy

for
Chemotherapy Induced Nausea and Vomiting
Location: Mount Olive AL
Sponsor: Simon Williamson Clinic

Sex: All

Age: 18+

Code: NCT06065722

Phase 2, Recruiting

Clinical Validation of the Aptitude Medical Systems Metrix COVID-19 Test

for
COVID-19, COVID
Location: Birmingham AL, Madison AL, Baton Rouge LA
Sponsor: Aptitude Medical Systems

Sex: All

Age: 2+

Code: NCT06744660

Recruiting

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

for
End Stage Kidney Disease
Location: Columbus MS, Tupelo MS, Decatur AL, Huntsville AL,
Sponsor: CSL Behring

Sex: All

Age: 18+

Code: NCT05485961

Phase 2, Phase 3, Recruiting

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Columbus MS, New Albany MS, Grenada MS, Oxford MS,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 0+

Code: NCT06031688

Phase 2, Recruiting

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Columbus MS, New Albany MS, Grenada MS, Oxford MS,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT06616584

Phase 2, Phase 3, Recruiting

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Columbus MS, New Albany MS, Grenada MS, Oxford MS,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT05642572

Phase 2, Recruiting